Fundraising Fox

Kristina Burow

Investor

Founder and Managing Partner at Pachamama Ventures · Managing Director at ARCH Venture Partners · Board director at Mirador Therapeutics · Board director at Treeline Biosciences · Board director at Neumora Therapeutics

United States

Writes $50K – $150M checks · typically $50K

About

Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.

Contact· self-published, not guessed

Likely email· guessed from name + firm domain, not firm-published

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices

Board director at Mirador Therapeutics

Intro paths

→

In turn, Kristina can intro founders to Mirador Therapeutics's investors below.

Mirador Therapeutics's investors · 3

ARCH Venture PartnersChicago · $50K – $250M checks · since 2024OrbiMedNew York · $1M – $75M checksSanofi VenturesCambridge · $5M checks

Co-founders at Mirador Therapeutics

MCMark C. McKenna
Mark C. McKennaExecutive Officer, Director

Board director at Treeline Biosciences

Intro paths

→

In turn, Kristina can intro founders to Treeline Biosciences's investors below.

Treeline Biosciences's investors · 8

Aisling CapitalNew York · since 2025ARCH Venture PartnersChicago · $50K – $250M checks · since 2025Casdin CapitalNew York · since 2025Fidelity InvestmentsBoston · since 2025GV (Google Ventures)Mountain View · $250K – $50M checks · since 2025OrbiMedNew York · $1M – $75M checks · since 2025Rock Springs CapitalBaltimore · since 2025T. Rowe PriceBaltimore · since 2025

Co-founders at Treeline Biosciences

JHJoshua H. Bilenker
Joshua H. BilenkerExecutive Officer, Director, Promoter
JE
Jeffrey EngelmanExecutive Officer, Director, Promoter
JB
Josh BilenkerFounder

Board director at Neumora Therapeutics

Intro paths

→

In turn, Kristina can intro founders to Neumora Therapeutics's investors below.

Neumora Therapeutics's investors · 8

ARCH Venture PartnersChicago · $50K – $250M checks · since 2023Catalio Capital Management, LPNew York · since 2020F-Prime CapitalCambridge · $3M – $10M checks · since 2023K2 HealthVenturesBoston · $10M – $100M checks · since 2020Mercury FundHouston · $250K – $4M checks · since 2020Newpath PartnersBoston · $50K – $10M checks · since 2020Premier PartnersSeoul · since 2020SoftBank Vision FundLondon · since 2020

Experience

  1. Pachamama VenturesFounder and Managing Partnercurrent2024 — presentSan Francisco Bay Area
  2. National Venture Capital AssociationMembercurrent2026 — present
  3. All RaiseAll Raise VC Emerging Manager Cohort 2025current2024 — present
  4. Alchemist AcceleratorMentorcurrent2024 — present
  5. VCFamiliaMembercurrent2024 — present
  6. Cleantech OpenMentorcurrent2024 — present
  7. Libra LeadersFounding Membercurrent2024 — present
  8. Top Tier ImpactMembercurrent2024 — present
  9. UnreasonableUnreasonable Mentorcurrent2023 — present
  10. Global Women in VCMembercurrent2023 — present
  11. Invest for BetterMembercurrent2023 — present
  12. WeInvest LatamMembercurrent2023 — present
  13. Climate VineFounding Fellowcurrent2023 — present
  14. Women and ClimateSpeakercurrent2023 — present
  15. Pipeline AngelsVC-in-Residencecurrent2022 — presentSan Francisco Bay Area
  16. 9Zero Climate Innovation HubClub Member2025 — 2026San Francisco, California, United States
  17. FIF CollectiveMember2024
  18. VC LabVC Lab Cohort 8 Graduate2022 — 2024
  19. VisaDirector of Finance2021 — 2024San Francisco, California, United States
  20. Vitalize Venture CapitalAngel Investor / Founding Member2021 — 2023

Skills & more

Microsoft Office Xp2Access17SAP3SharePoint3Eviews1Stata1SQL1Microsoft Office4Microsoft Access5Microsoft Excel1Deal Sourcing6Angel Investing5
+12 moreTraffic AnalysisForecastingFinancial ModelingFinancial AnalysisBudgetingProfitability AnalysisCost AccountingCost AllocationMonth End CloseVariance AnalysisP&L ManagementSales Compensation

Languages English · French · German · Spanish

  • "Establishing the Next Generation of Alternative Investment Firms" Certificate — National Association of Investment Companies (NAIC)
  • Climate Change for VCs — Terra.do
  • Tropical Forest Restoration & Agroforestry — Yale School of the Environment
  • I to the 4th Power — Clear Strategy Coaching
  • Venture Capital (VC) University — VC University
  • Strategic Thinking — LinkedIn
  • Microsoft Office Specialist (MOS) — Microsoft

From Kristina's professional profile.

Deals · 14

Autobahn Therapeutics, Inc.Board seat

via ARCH Venture Partners · filed Aug 2024 · $120M raise

Boundless BioBoard seat

via ARCH Venture Partners · filed May 2021 · $105.6M raise

Vividion TherapeuticsBoard seat

via ARCH Venture Partners · filed May 2019 · $82M raise

Beam TherapeuticsBoard seat

via ARCH Venture Partners · filed Mar 2019 · $83.6M raise

Vir BiotechnologyBoard seat

via ARCH Venture Partners · filed Jun 2018

Scholar Rock Holding Corp, Inc.Board seat

via ARCH Venture Partners · filed Jan 2018 · $47M raise

Sienna BiopharmaceuticalsBoard seat

via ARCH Venture Partners · filed May 2017 · $40.5M raise

TrelysBoard seat

via ARCH Venture Partners · filed Apr 2017 · $80K raise

BoragenBoard seat

via ARCH Venture Partners · filed Mar 2017 · $10.5M raise

MetacrineBoard seat

via ARCH Venture Partners · filed Nov 2016 · $37.8M raise

Scholar RockBoard seat

via ARCH Venture Partners · filed Jan 2016 · $40M raise

AgbiomeBoard seat

via ARCH Venture Partners · filed Aug 2015 · $34.5M raise

LyceraBoard seat

via ARCH Venture Partners · filed Jun 2015

ErascaQuoted

via ARCH Venture Partners · filed Apr 2020

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Per SEC Form D filings.

Colleagues at Pachamama Ventures

Karen Sheffield
Founder & Managing Partner at Pachamama Ventures

Frequently asked questions

Who is Kristina Burow?
Kristina Burow, a biotech VC leader building companies in emerging biology, focuses on transformative neuropsychiatry and schizophrenia drugs for biologically defined subgroups, helping create Neumora, Orbital Therapeutics and Boundless Bio.
Where does Kristina Burow work?
Kristina Burow is Founder and Managing Partner at Pachamama Ventures and Board director at Mirador Therapeutics and Board director at Treeline Biosciences and Board director at Neumora Therapeutics.
What does Kristina Burow invest in?
Kristina Burow invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
What check size does Kristina Burow write?
Kristina Burow typically writes checks of $50K – $150M.
What boards does Kristina Burow sit on?
Kristina Burow holds tracked board seats at Agbiome, Autobahn Therapeutics, Inc., Beam Therapeutics, Boragen, Boundless Bio, Gossamer Bio, Lycera, Metacrine, Metsera, Mirador Therapeutics.
Where did Kristina Burow go to school?
Kristina Burow studied at Texas McCombs School of Business (Master of Business Administration (MBA), Business Administration and Management); TCU Neeley School of Business (BBA, Finance/Accounting); Texas Christian University (Bachelor of Science, Economics).

Same school

Also attended Texas McCombs School of Business241

Bill GurleyGeneral Partner Emeritus at BenchmarkArnon DinurPartner at 83NorthMonica SolizDirector, Marketing at Sapphire VenturesDale ChangOperating Partner at Scale Venture PartnersJoel HemmertFinance/Legal/IR at 8VCMadison McDonaldFinance/Legal/IR at 8VC

+ 235 more

Also attended TCU Neeley School of Business27

Stephen CondonFinance/Legal/IR at 8VCLindel EakmanGeneral Partner at FoundryKaren SheffieldFounder & Managing Partner at Pachamama VenturesFederico RaneroVenture Partner at NazcaCaroline DelfinExecutive Office at Gold House VenturesChiharu IijimaAccounting at Gold House Ventures

+ 21 more

Also attended Texas Christian University63

Mason NystromInvestor at Pantera CapitalPaul LevineOperating Partner at Sapphire VenturesJack RobersonInvestor at 8VCMarshall PorterGeneral Partner at AlleyCorpConner LovelyInvestor at CapitalGJamie RosenInvestor at CapitalG

+ 57 more

Also attended Pontificia Universidad Católica del Perú13

Karen SheffieldFounder & Managing Partner at Pachamama VenturesMayra ArntzPrincipal at Building VenturesMartin SalasFounder & CEO Meraki at Taram CapitalGustavo Luna-VictoriaHead of Legal at BDev VenturesAlfredo Ramos CruzadoPortfolio Manager at NESsTGuillermo MirandaAdvisor at Reach Capital

+ 7 more

Shared employers

Also worked at National Venture Capital Association71

Jeremy LiewPartner at Lightspeed Venture PartnersByron DeeterPartner at Bessemer Venture PartnersNick WashburnSenior Managing Director, Intel Capital (North America)Tiffany SpencerHead of Marketing at Menlo VenturesKate MitchellFounder at Scale Venture PartnersAdam D'AugelliInvestor at True Ventures

+ 65 more

Also worked at All Raise54

Aileen LeeFounder & Managing Partner of Cowboy VenturesJess LeePartner and Chief Product Officer at Sequoia CapitalByron DeeterPartner at Bessemer Venture PartnersHolly MaloneyInvestment Team at General CatalystMaya MatthewsSenior Associate at March Capital PartnersStacey BishopPartner at Scale Venture Partners

+ 48 more

Also worked at Unreasonable34

Karen SheffieldFounder & Managing Partner at Pachamama VenturesAjaita ShahGeneral Partner Advisor at Beyond Capital VenturesKaitlyn TregenzaAdvisor at Emmeline VenturesPatricia WexlerFounder & General Partner at AvilaArturo ElizondoAdvisor at AvilaRegula ScheggFounding Partner, CFO & CCO at Circulate Capital

+ 28 more

Also worked at Invest for Better1

Karen SheffieldFounder & Managing Partner at Pachamama Ventures